Last year he was the 94th richest man in the world. Last week Adolf Merckle stepped in front of a train near his home in Blaubeuren, Germany. The suicide note he left behind has not been made public, but Merckle’s family said in a statement that “the distress to his firms caused by the financial crisis and the related uncertainties of recent weeks, along with the helplessness of no longer being able to act, broke the passionate family businessman.”
Last year he was the 94th richest man in the world. Last week Adolf Merckle stepped in front of a train near his home in Blaubeuren, Germany. The suicide note he left behind has not been made public, but Merckle's family said in a statement that "the distress to his firms caused by the financial crisis and the related uncertainties of recent weeks, along with the helplessness of no longer being able to act, broke the passionate family businessman."
For many, the fiscal malaise that grips the world is personal. For those like Merckle who still possess more than most, it is not a matter of money. It is loss -- loss of what they had, loss of self respect, loss of hope.
It is not a coincidence that the 1930s were a time of global conflict. We are already seeing signs of unrest. We will see more as the dregs of leadership harness suffering as their means to power. The consequences are all around us, on network newscasts and Internet video clips of the carnage in Gaza.
Is there anything more horrific than parents carrying their infants and little children through the dilapidated doors of an overburdened hospital? Can anything drive the feeling of helplessness deeper?
Put aside for the moment the political arguments of Hamas and Israel and the moral arguments they wage as the reasons to kill. See just the result of their actions -- death of hundreds who never picked up a rifle or otherwise sought the destruction of other human beings. Hundreds more will die, many for no other reason than a lack of medical equipment to save them.
Thousands of portable x-ray systems, ultrasound scanners, and patient monitors are gathering dust in warehouses, waylaid by an economy gone wrong. Many of these units are new, but many also are trade-ins, shrink-wrapped and stockpiled for sales that may or may not come.
Our industry is powerless to stop the killing. But it could provide medical equipment that could help stop the dying. Any of the half-dozen humanitarian organizations operating in Gaza could coordinate the delivery of this equipment. Physicians for Human Rights, an Israeli humanitarian organization, is pleading for ultrasound and x-ray machines, portable monitors, respirators, needles, catheters, surgical gloves, medical gases, endotracheal tubes, and screws and plates.
It is unconscionable to acquiesce to the helplessness that feeds conflict when we have the means to help, even if only a little bit. In doing so, we dispel the kind of helplessness that led Merckle to take his own life. We replace it with a sense of accomplishment that can be shared across the thousands who work in our industry. Most importantly, we provide hope to those most stricken, hope to hang on a little longer, maybe long enough to keep the horrors of war from spreading.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.